BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20671136)

  • 21. Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV.
    Ermel A; Tong Y; Tonui P; Orang'o O; Muthoka K; Wong N; Manai T; Kiptoo S; Loehrer PJ; Brown DR
    Int J STD AIDS; 2021 Nov; 32(13):1212-1220. PubMed ID: 34233531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women.
    Tong Y; Tonui P; Ermel A; Orang'o O; Wong N; Titus M; Kiptoo S; Muthoka K; Loehrer PJ; Brown DR
    SAGE Open Med; 2020; 8():2050312120945138. PubMed ID: 32782796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.
    Vänskä S; Luostarinen T; Lagheden C; Eklund C; Kleppe SN; Andrae B; Sparén P; Sundström K; Lehtinen M; Dillner J
    Am J Epidemiol; 2021 Apr; 190(4):506-514. PubMed ID: 32639531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HPV16 Genome Is Stable in Women Who Progress to
    Arroyo-Mühr LS; Lagheden C; Hultin E; Eklund C; Adami HO; Dillner J; Sundström K
    Cancer Res; 2019 Sep; 79(17):4532-4538. PubMed ID: 31289133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort.
    Bonde J; Bottari F; Parvu V; Pedersen H; Yanson K; Iacobone AD; Kodsi S; Landoni F; Vaughan L; Ejegod DM; Sandri MT
    Int J Cancer; 2019 Aug; 145(4):1033-1041. PubMed ID: 30895602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Eckert K; Kodsi S; Cooper C
    Am J Clin Pathol; 2019 Mar; 151(4):433-442. PubMed ID: 30649177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study.
    Arroyo-Mühr LS; Lagheden C; Hultin E; Eklund C; Adami HO; Dillner J; Sundström K
    Br J Cancer; 2018 Oct; 119(9):1163-1168. PubMed ID: 30344308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
    Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
    BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Papillomavirus (HPV) Infections and the Importance of HPV Vaccination.
    Wang CJ; Palefsky JM
    Curr Epidemiol Rep; 2015 Jun; 2(2):101-109. PubMed ID: 27500080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
    Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for Anal Cancer in Women.
    Moscicki AB; Darragh TM; Berry-Lawhorn JM; Roberts JM; Khan MJ; Boardman LA; Chiao E; Einstein MH; Goldstone SE; Jay N; Likes WM; Stier EA; Welton ML; Wiley DJ; Palefsky JM
    J Low Genit Tract Dis; 2015 Jul; 19(3 Suppl 1):S27-42. PubMed ID: 26103446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.
    Banister CE; Messersmith AR; Cai B; Spiryda LB; Glover SH; Pirisi L; Creek KE
    J Infect Dis; 2015 Jan; 211(1):100-8. PubMed ID: 25028692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.
    Zhang H; Mao Y; Zhang F; Ye C; Tong H; Su Y; Zhu J
    Mol Cell Biochem; 2014 Jun; 391(1-2):77-84. PubMed ID: 24567178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dilation and surgical management in vaginal agenesis: a systematic review.
    McQuillan SK; Grover SR
    Int Urogynecol J; 2014 Mar; 25(3):299-311. PubMed ID: 24114388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test.
    Halfon P; Lindemann ML; Raimondo A; Ravet S; Camus C; Khiri H; Pénaranda G; Sideri M; Sandri MT
    Arch Virol; 2013 Jun; 158(6):1143-9. PubMed ID: 23299934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updating the natural history of human papillomavirus and anogenital cancers.
    Moscicki AB; Schiffman M; Burchell A; Albero G; Giuliano AR; Goodman MT; Kjaer SK; Palefsky J
    Vaccine; 2012 Nov; 30 Suppl 5(0 5):F24-33. PubMed ID: 23199964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus persistence in young unscreened women, a prospective cohort study.
    Schmeink CE; Melchers WJ; Siebers AG; Quint WG; Massuger LF; Bekkers RL
    PLoS One; 2011; 6(11):e27937. PubMed ID: 22132173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-risk HPV infection after five years in a population-based cohort of Chilean women.
    Ferreccio C; Van De Wyngard V; Olcay F; Domínguez MA; Puschel K; Corvalán AH; Franceschi S; Snijders PJ
    Infect Agent Cancer; 2011 Nov; 6(1):21. PubMed ID: 22087645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.
    Sepkovic DW; Stein J; Carlisle AD; Ksieski HB; Auborn K; Raucci L; Nyirenda T; Bradlow HL
    Cancer Prev Res (Phila); 2011 Jun; 4(6):890-6. PubMed ID: 21383027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.